Live Breaking News & Updates on பால் டட்லி வெள்ளை சர்வதேச அறிஞர் விருது

Stay updated with breaking news from பால் டட்லி வெள்ளை சர்வதேச அறிஞர் விருது. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

VASCEPA® (Icosapent Ethyl) Found in Prespecified and Post Hoc Analyses to Significantly Reduce ...


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
VASCEPA® (Icosapent Ethyl) Found in Prespecified and Post Hoc Analyses to Significantly Reduce .
Amarin Corporation plcMarch 17, 2021 GMT
28% and 32% significant reductions in first and total strokes, respectively, demonstrated with VASCEPA compared to placebo, as well as reductions in first and total ischemic strokes each by 36%, without increasing hemorrhagic stroke, in statin-treated patients with elevated cardiovascular risk
Consistent reductions in overall stroke and in ischemic stroke observed across multiple subgroups
Administration of pure icosapent ethyl, VASCEPA, represents a novel clinical approach to stroke reduction
REDUCE-IT® STROKE abstract receives prestigious Paul Dudley White International Scholar Award to recognize the authors with the highest ranked abstract from the United States at the International Stroke Conference 2021 ....

United States , New Jersey , United Arab Emirates , Clin Cardiol , Coll Cardiol , Alina Kolomeyer , Steven Ketchum , Deepakl Bhatt , Paul Dudley White , American Heart Association , Harvard Medical School , Professor Of Medicine At Harvard Medical School , Exchange Commission , Paul Dudley White International Scholar Award , International Stroke Conference , Amarin Corporation , Journal Of The American College Cardiology , European Union , European Medicines Agency , Committee For Medicinal Products Human Use , A Report From The American Heart Association , Executive Director , Interventional Cardiovascular Programs , Paul Dudley White Award , New England Journal , American College ,

VASCEPA® (Icosapent Ethyl) Found in Prespecified and Post Hoc Analyses to Significantly Reduce Stroke in At-Risk Patients in Analyses of Landmark REDUCE-IT® Study Presented at International Stroke Conference 2021


Share:
28% and 32% significant reductions in first and total strokes, respectively, demonstrated with VASCEPA compared to placebo, as well as reductions in first and total ischemic strokes each by 36%, without increasing hemorrhagic stroke, in statin-treated patients with elevated cardiovascular risk
Consistent reductions in overall stroke and in ischemic stroke observed across multiple subgroups
Administration of pure icosapent ethyl, VASCEPA, represents a novel clinical approach to stroke reduction
REDUCE-IT® STROKE abstract receives prestigious Paul Dudley White International Scholar Award to recognize the authors with the highest ranked abstract from the United States at the International Stroke Conference 2021
DUBLIN, Ireland and BRIDGEWATER, N.J., March 17, 2021 (GLOBE NEWSWIRE) Amarin Corporation plc (NASDAQ:AMRN) today announced the presentation of REDUCE-IT® STROKE at the International Stroke Conference 2021, being held virtually from March 17 � ....

United States , New Jersey , United Arab Emirates , Clin Cardiol , Coll Cardiol , Alina Kolomeyer , Steven Ketchum , Deepakl Bhatt , Paul Dudley White , American Heart Association , Harvard Medical School , Professor Of Medicine At Harvard Medical School , Exchange Commission , Paul Dudley White International Scholar Award , International Stroke Conference , Amarin Corporation , Journal Of The American College Cardiology , European Union , European Medicines Agency , Committee For Medicinal Products Human Use , A Report From The American Heart Association , Executive Director , Interventional Cardiovascular Programs , Paul Dudley White Award , New England Journal , American College ,